Pretreatment T lymphocyte numbers are contributing to the prognostic significance of absolute lymphocyte numbers in B-cell non-Hodgkins lymphomas

Pathology and Oncology Research

Volumn 17, Issue 2, 2011, Pages 249-255

  Gergely, Lajos ^a   Váncsa, Andrea ^a,b   Miltényi, Zsófia ^a   Simon, Zsófia ^a   Baráth, Sándor ^a   Illés, Árpád ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Lymphocytes; NHL; Prognostic factors; T cells

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISOLONE; RITUXIMAB; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CANCER REGRESSION; CANCER RELAPSE; CANCER STAGING; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; FEMALE; FOLLICULAR LYMPHOMA; FOLLOW UP; HUMAN; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NATURAL KILLER CELL; NODAL MARGINAL ZONE LYMPHOMA; OVERALL SURVIVAL; PROGNOSIS; SMALL LYMPHOCYTIC LYMPHOMA; T LYMPHOCYTE SUBPOPULATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CELL COUNT; CELL SEPARATION; FEMALE; FLOW CYTOMETRY; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHOMA, B-CELL; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES; YOUNG ADULT;

EID: 80051665925     PISSN: 12194956     EISSN: 15322807     Source Type: Journal    
DOI: 10.1007/s12253-010-9306-2     Document Type: Article

References (17)

1. Yamaguchi M, Nakamura N, Suzuki R, Kagami Y, Okamoto M, Ichinohasama R et al (2008) De novo CD5+ diffuse large B-cell lymphoma: results of a detailed clinicopathological review in 120 patients. Haematologica 93(8):1195-1202
2. Marini G, Ippoliti G, Ascari E, Casirola G (1972) The absolute lymphocyte count in Hodgkin's disease as an aid in survival prognosis. Haematologica 57(12):822-831
3. Decaudin D, Des Guetz G, Mathiot C, Dumont J, Hubert P, Vincent-Salomon A et al (2003) Absolute lymphocyte count as a predictive factor for response to monoclonal anti-CD20 antibody therapy. Ann Oncol 14(1):171-172 (Pubitemid 36150279)
4. Siddiqui M, Ristow K, Markovic SN, Witzig TE, Habermann TM, Colgan JP et al (2006) Absolute lymphocyte count predicts overall survival in follicular lymphomas. Br J Haematol 134(6):596-601 (Pubitemid 44253601)
5. Czuczman MS, Grillo-Lopez AJ, Alkuzweny B, Weaver R, Larocca A, McLaughlin P (2006) Prognostic factors for non-Hodgkin's lymphoma patients treated with chemotherapy may not predict outcome in patients treated with rituximab. Leuk Lymphoma 47(9):1830-1840 (Pubitemid 44649768)
6. Wahlin BE, Sander B, Christensson B, Kimby E (2007) CD8+ T-cell content in diagnostic lymph nodes measured by flow cytometry is a predictor of survival in follicular lymphoma. Clin Cancer Res 13(2 Pt 1):388-397 (Pubitemid 46225341)
7. Kaplan E, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481
8. Crowley JJ, McCoy J (1993) Survival trees by goodness of split. J Am Stat Assoc 88:457-467
9. Cox DR (1972) Regression models and life tablets. J Roy Stat Soc, Senes to Applied Statistics 34:187-202
10. Delgado J, Pratt G, Phillips N, Briones J, Fegan C, Nomdedeu J et al (2009) Beta2-microglobulin is a better predictor of treatmentfree survival in patients with chronic lymphocytic leukaemia if adjusted according to glomerular filtration rate. Br J Haematol 145(6):801-805
11. Talaulikar D, Choudhury A, Shadbolt B, Brown M (2008) Lymphocytopenia as a prognostic marker for diffuse large B cell lymphomas. Leuk Lymphoma 49(5):959-964 (Pubitemid 351942751)
12. Oki Y, Yamamoto K, Kato H, Kuwatsuka Y, Taji H, Kagami Y et al (2008) Low absolute lymphocyte count is a poor prognostic marker in patients with diffuse large B-cell lymphoma and suggests patients' survival benefit from rituximab. Eur J Haematol 81(6):448-453
13. Cox MC, Nofroni I, Ruco L, Amodeo R, Ferrari A, La Verde G et al (2008) Low absolute lymphocyte count is a poor prognostic factor in diffuse-large-B-cell-lymphoma. Leuk Lymphoma 49(9):1745-1751
14. Kim DH, Baek JH, Chae YS, Kim YK, Kim HJ, Park YH et al (2007) Absolute lymphocyte counts predicts response to chemotherapy and survival in diffuse large B-cell lymphoma. Leukemia 21(10):2227-2230 (Pubitemid 47423827)
15. Seshadri T, Pintilie M, Keating A, Crump M, Kuruvilla J (2008) The relationship between absolute lymphocyte count with PFS in patients with Hodgkin's lymphoma undergoing autologous hematopoietic cell transplant. Bone Marrow Transplant 42(1):29-34 (Pubitemid 352003421)
16. De Angulo G, Yuen C, Palla SL, Anderson PM, Zweidler-McKay PA (2008) Absolute lymphocyte count is a novel prognostic indicator in ALL and AML: implications for risk stratification and future studies. Cancer 112(2):407-415
17. Yano Y, Ueda Y, Itoh T, Fuji N, Okugawa K, Naito K et al (2006) A new strategy using autologous dendritic cells and lymphokine-activated killer cells for cancer immunotherapy: efficient maturation of DCs by co-culture with LAK cells in vitro. Oncol Rep 16(1):147-152